Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Colombo
RidhMathraa ’26 🎶✨
Tmadhusanka
Updated:
Yesterday at 11:58 PM
Ad icon
Colombo
PXN V10 Pro Direct Drive Racing Wheel (Under Warranty)
Abdur Rahman
Updated:
Yesterday at 10:23 PM
Ad icon
USDT ණය සේවාව - USDT Loan Service
පුරවැසියා
Updated:
Yesterday at 4:54 PM
Ad icon
🎮 INDIAN PSN GIFT CARDS AVAILABLE NOW! 🎮
madukaperera
Updated:
Tuesday at 12:57 PM
🚀 Google AI PRO – 18 Months | Rs. 850 Only
lkkolla
Updated:
Monday at 4:56 PM
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
Pfizer CEO says third Covid vaccine dose likely needed within 12 months
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 26313766" data-attributes="member: 562115"><p>Most Generation-1 vaccines have a flaw.... simply because these target the "Spike Protein." Think what changes mostly with the variants? - The spike protein.</p><p></p><p>Some developers went for "Inactivated Vaccines" - eg China, India etc. Theoretically these should perform better and should have an edge over the other mRNA or viral vector methods. However, the inactivated vaccines has low efficacy and no one has really explained why.</p><p>So experts believe that the long term solution will not be inactivated vaccines, even though inactivated virus vaccines have an edge in initiating a T-cell response.</p><p>Hence Generation-2 covid vaccine research is on. Many believe these should target at least a part of the genetic code of the virus itself.</p><p></p><p>The only other option is to design an "Anti-Viral drug" that works... The new US administration placed funding for this.</p></blockquote><p></p>
[QUOTE="imhotep, post: 26313766, member: 562115"] Most Generation-1 vaccines have a flaw.... simply because these target the "Spike Protein." Think what changes mostly with the variants? - The spike protein. Some developers went for "Inactivated Vaccines" - eg China, India etc. Theoretically these should perform better and should have an edge over the other mRNA or viral vector methods. However, the inactivated vaccines has low efficacy and no one has really explained why. So experts believe that the long term solution will not be inactivated vaccines, even though inactivated virus vaccines have an edge in initiating a T-cell response. Hence Generation-2 covid vaccine research is on. Many believe these should target at least a part of the genetic code of the virus itself. The only other option is to design an "Anti-Viral drug" that works... The new US administration placed funding for this. [/QUOTE]
Insert quotes…
Verification
Haya warak paha keeyada? (haya wadi kireema paha)
Post reply
Top
Bottom